09 September 2014 3 6K Report

I am planning to use AAV vector to express a gene product in the brain in a standard protocol. I am in the process of getting biosafety approval.

I understand that AAV vector mediated expression lasts a long time, but how long does the vector itself continue to be active/infectious after injection?

The question is related to safety approval, essentially:

How long after AAV vector injection can the tissue be treated like wild type tissue with no infection risk? 

I found this article: Comp Med. Oct 2012; 62(5): 361–37 which suggest a about a week but have not found it easy to find corroborating evidence.

Thanks for your help

Similar questions and discussions